Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2006

4SC Achieves Milestone in Drug Discovery Collaboration in Diabetes

  • 4SC and Sanwa Kagaku Kenkyusho (SKK) completed their research collaboration in the field of diabetes, which was started in January 2005. The successful completion triggers another significant payment from SKK, which is now responsible for further R&D. 4SC continues to participate in future potential milestone and royalty payments.

    Under the terms of the agreement, 4SC applied its virtual high-throughput screening technology, 4SCan®, followed by biological screening experiments to identify active agents against specific targets provided by SKK. In a second step 4SC optimized these hits chemically with respect to certain properties like potency, selectivity, and their in vitro ADMET profile.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »